These findings not only demonstrate the increased expression of Nur77 during melanoma progression but also indicate that DdBIC has translational potential for the treatment of melanoma, particularly metastatic melanoma, through Nur77 regulation. This evidence concerns the gene NR4A1 and metastatic melanoma.